The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease?

[Image: see text] The treatment of Alzheimer's disease (AD) still remains an area of significant unmet need, with drugs that only target the symptoms of the disease. Therefore, there is considerable need for disease-modifying therapies. The complex etiology of AD prompts scientists to develop m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rampa, Angela, Bartolini, Manuela, Bisi, Alessandra, Belluti, Federica, Gobbi, Silvia, Andrisano, Vincenza, Ligresti, Alessia, Di Marzo, Vincenzo
Format: Artigo
Idioma:Inglês
Publicat: American Chemical Society 2012
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4025825/
https://ncbi.nlm.nih.gov/pubmed/24900454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml200313p
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars